Ignite Creation Date:
2025-12-24 @ 1:39 PM
Ignite Modification Date:
2026-02-20 @ 3:01 AM
Study NCT ID:
NCT00496795
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-06-29
First Post:
2007-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer
Sponsor:
Organization: